| Literature DB >> 21959328 |
Lin Yang1, Stefan Ma, Ping Yan Chen, Jian Feng He, King Pan Chan, Angela Chow, Chun Quan Ou, Ai Ping Deng, Anthony J Hedley, Chit Ming Wong, J S Malik Peiris.
Abstract
Influenza has been well documented to significantly contribute to winter increase of mortality in the temperate countries, but its severity in the subtropics and tropics was not recognized until recently and geographical variations of disease burden in these regions remain poorly understood. In this study, we applied a standardized modeling strategy to the mortality and virology data from three Asian cities: subtropical Guangzhou and Hong Kong, and tropical Singapore, to estimate the disease burden of influenza in these cities. We found that influenza was associated with 10.6, 13.4 and 8.3 deaths per 100,000 population in Guangzhou, Hong Kong and Singapore, respectively. The annual rates of excess deaths in the elders were estimated highest in Guangzhou and lowest in Singapore. The excess death rate attributable to A/H1N1 subtype was found slightly higher than the rates attributable to A/H3N2 during the study period of 2004-2006 based on the data from Hong Kong and Guangzhou. Our study revealed a geographical variation in the disease burden of influenza in these subtropical and tropical cities. These results highlight a need to explore the determinants for severity of seasonal influenza.Entities:
Mesh:
Year: 2011 PMID: 21959328 PMCID: PMC7115499 DOI: 10.1016/j.vaccine.2011.09.071
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641
Mean meteorology data, population and annual number of deaths in Guangzhou, Hong Kong and Singapore, 2004–2006.
| Guangzhou | Hong Kong | Singapore | |
|---|---|---|---|
| Latitude | 23°05′N | 21°45′N | 1°22′N |
| Temperature (°C) (SD) | 23.0 (5.8) | 23.4 (4.9) | 27.8 (0.9) |
| Humidity (%) (SD) | 70.0 (10.3) | 78.9 (7.5) | 83.6 (3.7) |
| Population (%) | |||
| All-ages | 3,716,329 (100.0%) | 6,817,933 (100.0%) | 4,277,967 (100.0%) |
| 65+ | 358,157 (9.6%) | 835,267 (12.3%) | 306,533 (7.2%) |
| Deaths (rate) | |||
| All-cause | |||
| All-ages | 23,084 (621) | 36,525 (536) | 16,093 (376) |
| 65+ | 17,328 (4838) | 28,877 (3457) | 10,726 (3499) |
| CRD | |||
| All-ages | 12,585 (339) | 16,264 (239) | 8349 (195) |
| 65+ | 10,961 (3060) | 14,601 (1748) | 6406 (2090) |
| P&I | |||
| All-ages | 522 (14) | 4030 (59) | 2298 (54) |
| 65+ | 453 (126) | 3792 (454) | 1933 (631) |
| COPD | |||
| All-ages | 2355 (63) | 2045 (30) | 574 (13) |
| 65+ | 2231 (623) | 1921 (230) | 476 (155) |
| IHD | |||
| All-ages | 2558 (69) | 3789 (56) | 2983 (70) |
| 65+ | 2190 (611) | 3313 (397) | 2146 (700) |
Note: SD, standard deviation.
Proportion of each age group in total population.
Death rate per 100,000 population.
Annual sum of total specimens tested and specimens positive for influenza by subtypes in Guangzhou, Hong Kong and Singapore, 2004–2006.
| Year | Virus type | Guangzhou | Hong Kong | Singapore |
|---|---|---|---|---|
| 2004 | Test specimens | 1895 | 28,345 | 7783 |
| A + B | 117 | 4956 | 294 | |
| A/H3N2 | 100 (85.5%) | 4605 (92.9%) | 67 (38.7%) | |
| A/H1N1 | 0 (0.0%) | 27 (0.5%) | 9 (5.2%) | |
| B | 17 (14.5%) | 324 (6.5%) | 97 (56.1%) | |
| 2005 | Test specimens | 1856 | 41,003 | 10,441 |
| A + B | 266 | 5894 | 462 | |
| A/H3N2 | 164 (61.7%) | 4511 (76.5%) | 75 (44.6%) | |
| A/H1N1 | 67 (25.2%) | 429 (7.3%) | 30 (17.9%) | |
| B | 35 (13.2%) | 954 (16.2%) | 63 (37.5%) | |
| 2006 | Test specimens | 1865 | 36,419 | 11,105 |
| A + B | 184 | 3881 | 535 | |
| A/H3N2 | 1 (0.5%) | 208 (5.4%) | 33 (14.9%) | |
| A/H1N1 | 115 (62.5%) | 2797 (72.1%) | 44 (19.8%) | |
| B | 68 (37.0%) | 876 (22.6%) | 145 (65.3%) | |
| Total | Test specimens | 5616 | 105,767 | 29,329 |
| A + B | 567 | 14,731 | 1291 | |
| A/H3N2 | 265 (46.7%) | 9324 (63.3%) | 175 (31.1%) | |
| A/H1N1 | 182 (32.1%) | 3253 (22.1%) | 83 (14.7%) | |
| B | 120 (21.2%) | 2154 (14.6%) | 305 (54.2%) |
Sum of influenza subtypes for Singapore is not equal to A + B because the specimens for subtyping were different from those tested for A + B.
Proportions of subtype in total positive specimens for influenza A + B.
Fig. 1Weekly proportions of specimens positive for influenza in Guangzhou, Hong Kong and Singapore, 2004–2006.
The excess death percentage (Excess %) and excess death rate per 100,000 population (Excess rate) associated with influenza in the three cities Guangzhou, Hong Kong and Singapore.
| Age | Disease | Guangzhou | Hong Kong | Singapore | |||
|---|---|---|---|---|---|---|---|
| Excess % (95% CI) | Excess rate (95% CI) | Excess % (95% CI) | Excess rate (95% CI) | Excess % (95% CI) | Excess rate (95% CI) | ||
| All-ages | All-cause | 1.7 (0.1, 3.3) | 10.6 (0.6, 20.5) | 2.5 (1.0, 3.9) | 13.4 (5.4, 20.9) | 2.2 (0.8, 3.6) | 8.3 (3.0, 13.5) |
| CRD | 2.9 (0.6, 5.2) | 9.8 (2.0, 17.6) | 4.0 (1.9, 6.1) | 9.5 4.5, 14.6) | 2.7 (0.9, 4.5) | 5.3 (1.8, 8.8) | |
| P&I | 6.8 (1.1, 12.2) | 1.0 (0.2, 1.7) | 7.8 (4.1, 11.3) | 4.6 (2.4, 6.7) | 5.2 (1.5, 8.7) | 2.8 (0.8, 4.7) | |
| COPD | 2.9 (−0.4, 6.1) | 1.8 (−0.3, 3.9) | 9.7 (5.7, 13.7) | 2.9 (1.7, 4.1) | −1.3 (−8.8, 6.1) | −0.2 (−1.2, 0.8) | |
| IHD | 4.5 (1.4, 7.5) | 3.1 (1.0, 5.2) | 3.5 | 1.9 (0.1, 3.8) | 2.2 (−0.9, 5.3) | 1.5 (−0.6, 3.7) | |
| 65+ | All-cause | 2.3 (0.4, 4.2) | 111.3 (19.4, 203.2) | 3.0 (1.3, 4.6) | 103.7 (44.9, 159.0) | 2.3 (0.5, 4.1) | 80.5 (17.5, 143.5) |
| CRD | 3.4 (0.9, 5.8) | 104.1 (27.5, 177.5) | 4.5 (2.3, 6.7) | 78.7 (40.2, 117.1) | 2.2 (0.0, 4.5) | 46.0 (0.0, 94.0) | |
Note: CI, confidence interval; CRD, cardiorespiratory diseases; P&I, pneumonia and influenza; COPD, chronic obstructive pulmonary diseases; IHD, ischemic heart diseases.
Fig. 2Annual excess all-cause mortality rates associated with influenza (per 100,000 population) between Guangzhou, Hong Kong and Singapore, all-ages group.
Fig. 3The excess death rates per 100,000 population associated with A subtypes A/H1N1 (H1), A/H3N2 (H3) and type B influenza in Guangzhou and Hong Kong, all-ages group. Note: CRD, cardiorespiratory diseases; P&I, pneumonia and influenza; COPD, chronic obstructive pulmonary diseases; IHD, ischemic heart diseases.